Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112160 · ClinicalTrials.gov registry record · Phase 2
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT04112160 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 125 participants.
The verdict
NCT04112160, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.
Interventions
- DRUG Ketorolac
- DRUG normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2019-08-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04112160
The ClinicalTrials.gov registry entry for NCT04112160 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT04112160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04112160 about?
NCT04112160 is a clinical study titled "Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal". This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.
What is the current status of trial NCT04112160?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2018-06-28. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT04112160?
The interventions under investigation include: Ketorolac (DRUG), normal saline (DRUG).
Who is sponsoring clinical trial NCT04112160?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.